Sidra Medicine highlights precision medicine breakthrough for rare genetic condition

Doha, Qatar:Sidra Medicine, Qatar s specialist women s and children s hospital and a member of Qatar Foundation, has highlighted the real world impact...

Doha, Qatar: Sidra Medicine, Qatar’s specialist women’s and children’s hospital and a member of Qatar Foundation, has highlighted the real-world impact of precision medicine on a six year old patient with a rare genetic condition.

Released to mark Rare Disease Day, the case shows how genomic research can directly inform clinical care and support early diagnosis and guided targeted treatment. The multidisciplinary team at Sidra Medicine also developed a personalised long-term preventive care plan.

“Precision medicine at Sidra Medicine is not confined to the laboratory—it is embedded into everyday clinical care, particularly for children with rare genetic conditions,” said Prof. Khalid Fakhro, Chief Research Officer at Sidra Medicine. “This case exemplifies how research and care work together to deliver earlier diagnoses, better outcomes, and truly personalised medicine for children and their families.”

At six years old, patient S, presented with velopharyngeal insufficiency (VPI), significant speech delay, and distinct craniofacial features. While these symptoms were initially managed through specialist clinical services, the combination and complexity of findings raised concerns that they may be part of an underlying genetic condition requiring further investigation.

“For years, we knew something was not right, but we did not have clear answers,” said the young girl’s family. “The uncertainty was difficult, and we were worried about her future. Receiving a definitive diagnosis helped us understand what she needed and gave us reassurance that she was finally receiving the right care.”